COMPANY

Ruskid LLC

“AT RUSKID, OUR MISSION IS TO OPTIMIZE PERI-OPERATIVE PATIENT CARE THROUGH THE DEVELOPMENT OF ADVANCED MONITORING TECHNOLOGIES.” Source · checked Oct 13, 2026

Location: Rancho Santa Fe, CA · source · Oct 13, 2026

Profile checked Oct 13, 2026

1 sourcedFunding itemssee sources below

Sourced facts

Each item links to its source and was checked by an independent review on Oct 13, 2026 (San Diego batch).

Therapeutic areas or services

peri-operative · ruskid.com · checked Oct 13, 2026

Focus / stage (company wording)

peri-operative · ruskid.com · checked Oct 13, 2026

Headquarters address

HQ: Rancho Santa Fe, CA · sec.gov · checked Oct 13, 2026

Funding (company or press release)

Total Amount Sold $ 1,370,000 · sec.gov · checked Oct 13, 2026

Funding and NIH signals

SEC Form D raise Raised $1.37M (Form D filed Feb 13, 2026). SEC Form D 0002110722-26-000001 (Feb 13, 2026)
Evidence (1 event)
- Feb 13, 2026 · SEC Form D 0002110722-26-000001
  Name of Issuer: RUSKID LLC; CIK: 2110722; Address: Rancho Santa FE, CA; Submission type: D; Filing date: 2026-02-13; Industry Group: Biotechnology; Date of First Sale: 2026-01-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 1370000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals